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Coronaviruses are well known for their potential to 
change their host or tissue tropism, resulting in unpredictable 
new diseases and changes in pathogenicity; severe 
acute respiratory syndrome and feline coronaviruses, 
respectively, are the most recognized examples. Feline 
coronaviruses occur as 2 pathotypes: nonvirulent feline 
enteric coronaviruses (FECVs), which replicate in intestinal 
epithelium cells, and lethal feline infectious peritonitis 
viruses (FIPVs), which replicate in macrophages. Evidence 
indicates that FIPV originates from FECV by mutation, 
but consistent distinguishing differences have not been 
established. We sequenced the full genome of 11 viruses 
of each pathotype and then focused on the single most 
distinctive site by additionally sequencing hundreds of 
viruses in that region. As a result, we identiﬁ  ed 2 alternative 
amino acid differences in the putative fusion peptide of the 
spike protein that together distinguish FIPV from FECV in 
>95% of cases. By these and perhaps other mutations, 
the virus apparently acquires its macrophage tropism and 
spreads systemically.
C
oronaviruses (subfamily Coronavirinae, order Nido-
virales) are enveloped, plus-strand RNA viruses that 
infect mammals and birds. They are quite common and 
cause infections in humans and a wide variety of animals; 
infection typically results in respiratory or enteric disease. 
Severe acute respiratory syndrome coronavirus (SARS-
CoV), which emerged suddenly in 2002 and caused severe 
acute respiratory disease in humans, is the most notorious 
coronavirus. SARS-CoV spread rapidly around the globe, 
infecting thousands and killing ≈800 persons. The virus 
presumably originated from bats and was transmitted to 
humans either directly or by using civets or raccoon dogs 
as intermediate hosts (1,2).
SARS-CoV best illustrates the remarkable potential 
for CoVs to change their tropism. Tropism switching 
has been implicated in the zoonotic emergence of 
human coronavirus OC43 from a bovine coronavirus 
and in turning transmissible gastroenteritis virus, an 
enteric porcine coronavirus, into porcine respiratory 
coronavirus, a respiratory pathogen (3,4). Such changes 
can be accompanied, although not necessarily, by cross-
species transmissions; thus, the erratic occurrence and 
unpredictable new disease manifestations of tropism 
switching are a matter of public health concern.
The feline coronaviruses (FCoVs) present an example 
of pathogenetic change apparently associated with tropism 
switching. These viruses occur as 2 pathotypes with an 
enigmatic, even controversial, relationship: the low-
virulence or nonvirulent feline enteric coronavirus (FECV) 
and the highly lethal feline infectious peritonitis virus 
(FIPV). FECV and FIPV are considered independently 
circulating viruses by some investigators (5,6). However, 
accumulating evidence supports the mutation hypothesis, 
which proposes that FIPV evolves from FECV by mutation 
in individually infected cats (7–12). A responsible 
mutation(s) has not been identiﬁ  ed to back this hypothesis.
FECV is ubiquitous and spreads efﬁ  ciently  by 
the fecal-oral route; hence, seropositivity among cat 
populations can reach 90%, depending on the ﬁ  eld 
conditions (13). The infection is restricted to the enteric 
tract, where the virus replicates in epithelial cells lining 
the gut mucosa. FECV infection is mild, causing transient 
enteritis that often passes unnoticed. The infection cannot 
be cleared efﬁ  ciently by the immune system and thus 
persists, often for weeks or months, sometimes even longer 
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(14–18). In contrast, FIPV is rare, but the consequences 
of infection are devastating. FIPV infection causes a 
progressive systemic disease called feline infectious 
peritonitis. The disease affects many organs, usually 
inducing fatal immunopathologic disease characterized 
by disseminated pyogranulomas and severe inﬂ  ammatory 
damage to serosal membranes.
In the past, sequence differences in several virus 
genes, including those encoding membrane and spike 
(S) structural proteins and the so-called group-speciﬁ  c 
proteins 3c and 7b, have been implicated in the FCoV 
virulence shift (5–7,10,11,19–22). However, none of these 
differences appeared to consistently correlate with disease 
phenotype. To establish a consistent cause for a virulence 
shift in FCoV, speciﬁ   cally the predominant serotype I 
FCoV, we sequenced the entire genome of several FECV 
and FIPV specimens and then concentrated on the most 
conspicuous region of consistent difference by collecting 
and sequencing additional FECV and FIPV samples.
Materials and Methods
Viruses and Clinical Specimens
FECV strain RM and FECV strain UCD (FECV UU2) 
were propagated in speciﬁ  c pathogen–free cats. FIPV UU3 
was obtained from a lymph node of a cat infected with 
FECV UCD; the presence of feline infectious peritonitis in 
the cat was pathologically conﬁ  rmed. During 2006–2011, 
with the assistance of veterinarians in the Netherlands, 
we randomly obtained ﬁ   eld cats with suspected feline 
infectious peritonitis and feces samples from apparently 
healthy cats from all geographic areas of the Netherlands; 
we did not use any selection criteria, such as age, sex, or 
breed of cat. Cats originated from 144 different catteries and 
single- and multicat households. Cats were pathologically 
diagnosed with feline infectious peritonitis by postmortem 
examination at the Veterinary Pathology Department, 
Utrecht University; ﬁ  ndings conﬁ  rmed that the cats had 
feline infectious peritonitis. Ascites samples and lesions 
from affected organs were obtained for RNA isolation. 
Fecal material from apparently healthy cats was obtained 
from the rectum by using a cotton swab.
RNA Preparation
We suspended fecal specimens to a ﬁ  nal concentration 
of 10% (wt/vol) in phosphate-buffered saline by vigorously 
vortexing the specimens. The supernatant was cleared 
(centrifugation for 10 min at 3,000 × g) and then used for 
RNA extraction. Following the manufacturer’s protocols, we 
used the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, 
CA, USA) to extract viral RNA from 140 μL of fecal 
supernatants or ascites and the QIAamp RNeasy Mini Kit to 
extract viral RNA from 30 mg of organ tissue homogenate.
FCoV Detection and Serotyping
We tested RNA isolated from organs or ascites of 
cats with feline infectious peritonitis and from feces of 
apparently healthy cats for the presence of FCoV RNA 
by using a reverse transcription nested PCR (RT-nPCR) 
targeting the highly conserved 3× untranslated region (23). 
Samples with results positive for FCoV were checked for 
the virus serotype by using an RT-nPCR targeting the S 
gene (24). Only samples positive for serotype I FCoV were 
included in this study.
We determined the sequence in the S gene region of 
interest by using an RT-nPCR. In brief, we synthesized 
complementary DNA by using an antisense primer 
(5′-CCCTCGAGTCCCGCAGAAACCATACCTA-3′) and 
superscript II reverse transcriptase (Promega, Madison, WI, 
USA) at 50°С for 1 h. We then performed the PCR by using 
Taq DNA polymerase (Promega) and speciﬁ  c primers (sense 
5′-CAATATTACAATGGCATAATGG-3′, antisense 5′-CC
CTCGAGTCCCGCAGAAACCATACCTA-3′) for the ﬁ  rst 
reaction and speciﬁ   c primers (sense 5′-GGCATAATG
GTTTTACCTGGTG-3′, antisense 5′-TAATTAAGCCT
CGCCTGCACTT-3′) for the second reaction. PCR cycling 
conditions were 30 cycles at 94°С for 60 s, at 50°С for 30 s, 
and at 72°С for 1 min plus a 7-min extension at 72°С at the 
end of the reaction. All enzymes were used according to the 
manufacturer’s instructions. Primer pairs were expected to 
generate a 598-bp product for the ﬁ  rst PCR run and a 142-
bp product for the second run.
Representative PCR products were puriﬁ  ed  by 
electrophoresis in 2% agarose gel followed by extraction 
from the gel by using a gel extraction kit (QIAGEN) 
according to the manufacturer’s recommended instructions. 
Macrogen Inc. (http://dna.macrogen.com/eng/) sequenced 
the gel-puriﬁ  ed DNA.
Full Genome Sequencing
Two 96-well plates of degenerate primers (online 
Technical Appendix, www.cdc.gov/eid-static/spreadsheets/
12-0143-Techapp.xls) were designed from aligned 
reference genomes by using a computational PCR primer 
design pipeline. The pipeline was developed at the J. Craig 
Venter Institute (JCVI) to produce tiled amplicons with an 
optimal length of 550 bp, with 100-bp overlap to provide 
6-fold sequence coverage of the genome. An M13 sequence 
tag was added to the 5× end of each degenerate primer 
and was used for sequencing. Primers were arranged in a 
96-well plate format, and all PCRs for each sample were 
performed in 2 plates. The primers used in this study are 
listed in the online Technical Appendix.
Sequencing reactions were performed by using Big 
Dye Terminator (Applied Biosystems, Foster City, CA, 
USA) chemistry. Each amplicon was sequenced from both 
ends by using M13 primers, and sequencing reactions 
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were analyzed by using a 3730 ABI sequencer (Applied 
Biosystems). Raw sequence data were trimmed to remove 
any primer-derived and low-quality sequence; gene 
sequences were assembled by using a viral assembly tool 
(www.jcvi.org/cms/research/software). Assemblies were 
edited computationally and manually. When insufﬁ  cient 
underlying sequence information was obtained, the sample 
was entered into the secondary sequencing pipeline and 
reampliﬁ  ed by using existing primers or primers designed 
from the problematic sequence assembly itself. The 
reampliﬁ  ed sample was then sequenced again.
An RNA virus genome prediction program called 
VIGOR (Viral Genome ORF Reader, JCVI (www.jcvi.
org/vigor) can decode many classes of viruses, taking into 
account virus-speciﬁ  c features, such as alternative splicing, 
internal open reading frames, and ribosomal slippage. 
This program was used to annotate de novo assemblies of 
coronaviruses sequenced at JCVI and also to validate newly 
assembled genomes during the ﬁ   nishing process. Last, 
we performed a quality control assessment and manually 
inspected the gene predictions before loading them into 
the annotation database at JCVI, from which they were 
exported in formats acceptable to the National Center for 
Biotechnology Information.
Multiple-Sequence Alignment
The full-length and partial FCoV genomic nucleotide 
sequences we obtained were deposited in the National 
Center for Biotechnology Information database (www.ncbi.
nlm.nih.gov). The sequence accession numbers of the full-
length FCoV sequences used in this study are listed in Table 
1. The GenBank accession numbers for the partial S gene 
sequences are JQ304323–JQ304518. Multiple-sequence 
alignments were constructed by using Clustal W (www.ebi.
ac.uk/clustalw) with the Lasergene MegAlign (DNASTAR, 
www.dnastar.com/t-sub-products-lasergene-megalign.
aspx) and MEGA4 (www.megasoftware.net) software 
programs. To identify key differences between FIPV and 
FECV, we analyzed their genomes and proteomes; for each 
nucleotide or amino acid position, we determined the rate 
at which FIPVs differed from all FECVs at that position. 
Phylogenetic analysis was performed by using features of 
the MEGA4 suite of programs. Phylogenetic trees of these 
sequences were obtained by using the neighbor-joining 
method. The bootstrap consensus tree, inferred from 1,000 
replicates, was prepared; positions containing gaps and 
missing data were eliminated from the dataset.
Results
Full Genome Sequencing
To identify the distinguishing difference(s) between the 
FCoV pathotypes, we initiated a full genome sequencing 
program of FECVs found in the feces of apparently healthy 
cats and of FIPVs found in organs or ascites of cats with 
pathologically conﬁ   rmed feline infectious peritonitis. To 
obtain a more extensive analysis of the coronavirus genome, 
this sequencing program is still ongoing; however, after the 
sequences of 11 genomes of each pathotype were completed, 
we performed a comparative FECV–FIPV analysis, 
screening the genomes for nucleotide differences (Table 1). 
This was done by counting, for every nucleotide position, 
the number of FIPV genomes for which the identity at that 
position differed from that in all FECV genomes.
Our results showed that differences were scattered 
along the entire genome (Figure 1). At 2,963 (10%) of the 
29,277 genome positions, the nucleotide identity in at least 
1 of the 11 FIPVs did not occur in any of the 11 FECVs. 
Of these 2,963 positions, 1,187 occurred in gene 1ab, 1,246 
in the S gene, 248 in gene cluster 3abc, 22 in the envelope 
protein gene, 42 in the membrane protein gene, 113 in the 
nucleocapsid protein gene, and 106 in gene cluster 7ab, 
showing the disproportionally large genetic variation in the 
S gene. The frequency with which differences occurred at 
different nucleotide positions across the genome showed 
the following distribution: a difference was detected 1× at 
1,914 positions, 2× at 945 positions, 3× at 87 positions, 4× 
at 15 positions, and 5× at 1 position. At 1 position (23531), 
the nucleotide identity in 9 of the FIPVs was not found in 
any of the FECVs. No position(s) uniquely distinguished 
the 2 FCoV pathotypes.
Nucleotide identity differed the most at position 
23531: it was highly conserved (100% A) in all FECV 
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Table 1. GenBank accession numbers for viruses for which the 
genomes were fully sequenced in a study to distinguish virulent 
from nonvirulent feline coronaviruses 
Virus strain  Accession no. 
Feline infectious peritonitis viruses   
 UU3  FJ938061 
 UU4  FJ938054 
 UU5  FJ938056 
 UU8  FJ938055 
 UU9  FJ938062 
 UU15  FJ938057 
 UU16  FJ938058 
 UU17  HQ012367 
 UU21  HQ012369 
 UU24  HQ012370 
 UU30  HQ392472 
Feline enteric coronaviruses   
 RM  FJ938051 
 UU2  (UCD)  FJ938060 
 UU7  FJ938053 
 UU10  FJ938059 
 UU11  FJ938052 
 UU18  HQ012368 
 UU19  HQ392490 
 UU20  HQ392471 
 UU22  GU553361 
 UU23  GU553362 
 UU31  HQ012371 RESEARCH
genomes, and it was C or T in 9 of the 11 FIPV genomes. 
This difference occurs in the S gene and results in an amino 
acid difference in the predicted S protein. Thus, although 
all FECV S proteins have a methionine at position 1058, 
a leucine is encoded in the 9 FIPVs, irrespective of the 
identity of the genetic difference (C or T).
Sequencing of the S gene
To further investigate the single most prominent region 
of difference between FECVs and FIPVs, we established 
an RT-nPCR method to amplify and analyze the genomic 
region covering nucleotides 23442–24040 for the ﬁ  rst PCR 
run and nucleotides 23451–23593 for the second run, which 
includes deviant position 23531. Altogether, 183 FECV 
and 118 FIPV RNAs isolated from different cats were 
sequenced in this speciﬁ  c region. Results for the 11 entirely 
sequenced FECVs and FIPVs are shown in Figure 2. The A 
at nucleotide 23531 was 100% conserved in all 183 FECVs 
in our collection. Of the 118 FIPVs, 96 (81.4%) had a T and 
12 (10.2%) a C at this position; in both cases, this changes 
the methionine occurring at position 1058 in the FECV S 
protein into a leucine in FIPV (i.e., mutation M1058L).
Phylogenetic Analysis
Assuming that the difference observed in 108 of the 
118 sequenced FIPVs may be responsible for the virulent 
phenotype, the remaining 10 viruses should be expected to 
carry alternative differences. In search of those differences, 
we performed a phylogenetic analysis of the partial nucleotide 
sequences accumulated by the RT-nPCR procedure, but 
the results did not enable further differentiation (data not 
shown). When carrying out a phylogenetic analysis of the 
translated partial amino acid sequences, we observed a 
small but distinct second cluster B in addition to the major 
cluster A constituted by the FIPVs having leucine at position 
1058 in their S protein (Figure 3). This smaller cluster, 
formed by 5 (4.2%) of the sequenced FIPVs, appeared to 
be characterized by the occurrence of an alanine at position 
1060 (i.e., mutation S1060A), just 2 residues downstream 
of the M1058 that is changed in most FIPVs. All other FIPVs 
and all sequenced FECVs consistently had a serine at this 
position. The difference is brought about in all 5 cases by a 
T→G change at nucleotide 23537. Overall, we have detected 
characteristic differences with FECV for 113 (95.8%) of the 
118 sequenced FIPVs. These differences were observed in 
both pathologic forms (i.e., wet and dry forms) of feline 
infectious peritonitis (Table 2).
Discussion
Our ﬁ  ndings show differences in 2 alternative codons 
of the FCoV S gene that correlate with the feline infectious 
peritonitis disease phenotype in >95% of cases. Besides 
providing a realistic basis for diagnostic discrimination 
of the 2 FCoV pathotypes, our ﬁ  ndings also support the 
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Figure 1. Comparison of full genomes of 11 lethal feline infectious 
peritonitis viruses (FIPVs) with full genomes of 11 nonvirulent feline 
enteric coronaviruses (FECVs). Nucleotide (nt) positions are shown 
on the x-axis; y-axis indicates number of FIPV genomes for which 
the identity at the nt position differed from identity at same position 
in all FECV genomes. FIPV strain C1Je (GenBank accession no. 
DQ848678) was used as the reference for nt numbering. *Highest 
difference score: 9 FIPVs had identities at nt position 23531 
that differed from those at the same position in all FECVs. 1a, 
gene 1a; 1b, gene 1b; S, spike protein gene; 3abc, gene cluster 
3abc; E, envelope protein gene; M, membrane protein gene; N, 
nucleocapsid protein gene; 7ab, gene cluster 7ab. 
Figure 2. Alignment of partial nucleotide sequences and translated 
amino acid sequences in the spike protein of 11 strains each 
of 2 feline coronavirus pathotypes: FIPVs (lethal) and FECVs 
(nonvirulent). The viruses were sequenced in a study to distinguish 
virulent from nonvirulent feline coronaviruses (see Table 1). FIPV 
strain C1Je (GenBank accession no. DQ848678) was used as the 
reference for numbering. Sequence positions are shown along 
the top; virus strains are shown on the right. Speciﬁ  c differences 
between the pathotypes are boxed. FIPVs, feline infectious 
peritonitis viruses; FECVs, feline enteric coronaviruses.Feline Coronavirus Virulence
mutation hypothesis. Thus, we propose that alternative 
mutations in the S protein of FECV give rise to a tropism 
change that allows the virus to escape from the intestine into 
body tissues, where it causes feline infectious peritonitis. 
Proof of this hypothesis will require introduction of these 
mutations into the FECV genome and demonstration of the 
virulence switch by infection of cats. However, this is a 
formidable challenge in the absence of a reverse genetics 
system and a proper cell culture system to generate and 
propagate these viruses.
Our  ﬁ   ndings relating the S protein to FCoV 
pathogenicity are not surprising, given earlier explorations 
into the involvement of various genes (7a, 7b, M, and 
3c) (5–7,10,11,19–22,24,25). One of the most notable 
consequences of the presumed mutation in FECV is the 
acquisition of monocyte/macrophage tropism by the 
resulting virus (26). Thus, whereas replication of FECV is 
restricted to the epithelial cells lining the gut, the virulence 
mutation enables FIPV to efﬁ  ciently infect and replicate in 
macrophages and spread the infection systemically (26). 
Such tropism change corresponds most logically with 
a modiﬁ  cation in the S protein. An earlier study, using 
serotype II FCoVs, indicated a virulence role for the S 
protein (21); however, identiﬁ   cation of the mutation(s) 
was not pursued because of the controversial nature of the 
FECV strain used in the study (14).
As for the serotype II viruses, the putative virulence 
mutations detected in the serotype I FCoV spike occur 
in the membrane-proximal domain of the protein. In 
coronaviruses, the S protein functions in cell entry; it is 
responsible for receptor attachment and membrane fusion. 
While the receptor binding site is located in the N terminal 
part of the protein, fusion is mediated by its membrane-
proximal part. Coronavirus S proteins are class I fusion 
proteins, which typically contain domains instrumental for 
this process: 2 heptad repeat regions and a fusion peptide 
(27). The fusion peptide is located just upstream of the 
membrane-distal heptad repeat region, but it remains to be 
proven that it functions as a fusion peptide. The 2 putative 
virulence mutations identiﬁ  ed in our study, M1058L and 
S1060A, map to this characteristic hydrophobic domain. 
Both changes are subtle and do not give clues as to their 
functional consequences. We assume, however, that these 
alternative mutations have a similar effect, and we speculate 
that the mutations in the remaining 4% of cases might also 
occur in the fusion peptide of the S protein.
If these mutations are all that is needed to convert a 
nonvirulent FECV into a lethal FIPV, the question arises as 
to why feline infectious peritonitis occurs so infrequently. 
For example, simple calculations based on a 10−4 frequency 
and a stochastic occurrence of RNA polymerase errors 
across the genome (28) predict that the M1058L mutation, 
for which 2 alternative substitutions of A23531 (to T or G) 
occur, would statistically arise once in every 1.5 × 104 
genomes produced. In experimental FECV infection of 
kittens, we showed that up to 108 genome equivalents of 
the virus are shed per microliter of feces (18); thus, typical 
FECV infections would be expected to generate thousands 
of progeny carrying 1 of the critical mutations. However, 
the virulence phenotype supposedly associated with the 
mutation is not observed to any proportional extent. We 
can only speculate as to the reasons.
One likely possibility is that additional mutations (1 
or more, perhaps alternative mutations) are required to 
generate the virulent pathotype. Such mutations would 
most probably involve the accessory gene 3c, which 
is intact in FECVs but severely affected in about two 
thirds of FIPVs (7,10–12). The 3c protein apparently is 
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Figure 3. Phylogenetic tree based on partial amino acid sequences 
(aa 1056–1069) of the spike proteins of 118 feline infectious 
peritonitis viruses (FIPVs) and 183 feline enteric coronaviruses 
(FECVs) obtained by using reverse transcription nested PCR and 
sequencing of the distinguishing genomic region. A circular rooted 
neighbor-joining tree was constructed by using the bootstrap 
method and applying 1,000 replicates. Black dots indicate FIPVs. 
Clade A comprises FIPVs containing the M1058L mutation; clade B 
comprises FIPVs containing the S1060A mutation.
Table 2. Prevalence of alternative mutations in feline infectious 
peritonitis virus spike protein of cats with wet and dry forms of 
FIP*
Mutation
Pathologic form of FIP 
Wet   Dry 
M1058L 71  46 
S1060A 5  1 
No mutation  3  3 
Total 79  50 
*Cats were diagnosed with the dry or wet form of FIP (feline infectious 
peritonitis) during postmortem examination by a veterinary pathologist. 
The occurrence and nature of the mutation in the spike gene was 
established by sequencing. RESEARCH
essential for replication of FECV in the gut but becomes 
nonessential once virulence mutation(s) elsewhere in the 
genome (e.g., in the S gene) enable the virus to infect 
macrophages and spread systemically. As we suggested 
earlier, loss of 3c function may not only be tolerated, it 
may even enhance the ﬁ  tness of the mutant virus in its 
new biotope and, as a consequence, hamper its return to 
the gut. If the mutant virus is absent in the gut, it will 
not be shed in feces, providing an explanation for the 
seemingly rare incidence of feline infectious peritonitis 
outbreaks. Our discoveries of the critical differences 
between FECVs and FIPVs are clearly only a small step 
toward understanding the pathogenetic phenomena of 
feline coronavirus infections.
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